• Product NameTorcetrapib
• Brief DescriptionInhibitors
• Purification98.89%
• Biological ActivityTorcetrapib is a CETP inhibitor with IC50 of 37 nM, elevates HDL-C and reduces nonHDL-C in plasma. Phase 3.
• Target NameCETP inhibitor
• CAS No. 262352-17-0
• Calculated MW 600.47
• Formulation C26H25F9N2O4
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cancer
  SMILES:CC[C@@H]1C[C@@H](C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(=O)OC
  Pathways:Metabolism
  Receptor:CETP
  Boling pt:
  Melting pt:
  Solubility:Ethanol: 6 mg/mL (9.99 mM); DMSO: 120 mg/mL (199.84 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Clark RW, et al. Arterioscler Thromb Vasc Biol, 2004, 24(3), 490-497.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting